M&A
confidence high
sentiment neutral
materiality 0.75
Stockholders approve business combination with Alps Life Sciences; 59,966 shares redeemed
GLOBALINK INVESTMENT INC.
- All three proposals approved unanimously: Redomestication Merger, Acquisition Merger, and Net Tangible Asset Charter Amendment.
- Holders of 59,966 public shares redeemed for cash, leaving 12,635 public shares outstanding.
- Special meeting quorum of 3,445,007 shares; no votes cast against any proposal.
- Adjournment proposal not presented due to sufficient favorable votes.